Professor
Rush University
Andrew Stephenson, M.D., is the Director of Urologic Oncology at Rush University. His clinical and research focus is the treatment of patients with cancers of prostate, bladder, testis, and kidney. He has published over 150 articles in peer-reviewed journals on issues related to prostate, bladder, kidney and testis cancer. Dr. Stephenson is board-certified in urology by the American Board of Urology and the Royal College of Physicians and Surgeons of Canada. He has received several awards from organizations such as the Prostate Cancer Foundation, American Society of Clinical Oncology, and Society of Urologic Oncology. He is listed as one of the Best Doctors in America. He is a past recipient of the Urology Teacher of the Year award from Rush University and Cleveland Clinic and the Young Investigator Award from the Society of Urologic Oncology. He has also been recognized as a Rising Star in Urology by the American Urological Association. Dr. Stephenson receives grant support for prostate cancer research from the Robert Wood Johnson Foundation, American Cancer Society, and the Urology Care Foundation. His research focus is on improving decision-making for patients and physicians for complex urological cancers. He is on the editorial board for several urology and oncology journals. He is Chair of the AUA/ASCO Testicular Cancer Guidelines Comittee.
Disclosure information not submitted.
Sunday, April 30, 2023
7:30 AM – 9:30 AM CST